Is 0.01% Atropine Sulfate Eye Drops suitable for children? How to use it correctly?

0.01% Atropine Sulfate Eye Drops (EIKANCE) is a low-concentration atropine drug that is widely used to control the progression of myopia in children. Atropine is an anticholinergic drug that can slow down the growth of the eyeball by relaxing the ciliary muscles of the eye, thereby effectively controlling the progression of myopia. Low-concentration 0.01%atropine sulfate eye drops are considered a safe and effective treatment for children, especially adolescents, to slow the progression of myopia.

According to multiple clinical studies,0.01%Atropine Sulfate Eye Drops have shown good efficacy in controlling myopia in children. Studies have shown that low-concentration atropine eye drops can effectively slow down the progression of myopia, especially in preschool and school-age children, and have good therapeutic effects. At the same time, compared with traditional high-concentration atropine, low-concentration atropine of 0.01% has fewer side effects and is less likely to cause obvious discomfort symptoms such as mydriasis and blurred vision when used by children, so it is more suitable for long-term use.

0.01%Atropine sulfate eye drops are usually used once daily in the evening. Pediatric patients need to use eye drops according to the doctor's recommendations. Generally speaking, 1 to 2 drops should be applied to each eye. The specific dosage should be adjusted according to individual conditions and the guidance of a doctor. Before use, make sure your hands are clean and avoid touching the mouth of the eye drop bottle with your fingers to reduce the risk of contamination. Raise your head, pull down your eyelids, drop eye drops into your eyes, close your eyes and gently press the inner corners of your eyes for 1 to 2 minutes to help the medicine be better absorbed and reduce the outflow of the medicine. Avoid rubbing your eyes after each eye drop.

0.01%Atropine sulfate eye drops (EIKANCE) are widely used in the control of myopia in children. Due to its low concentration, it has fewer side effects and is suitable for long-term use. Correct use and following your doctor's recommendations are key to ensuring its efficacy and safety. For children whose myopia deepens quickly, the use of this drug can effectively slow down the development of myopia, reduce the increase in myopia degree, and provide effective protection for children's visual health.

Reference materials:https://www.medsafe.govt.nz/profs/datasheet/e/EikanceEyeDrops.pdf